While every person on this planet is affected by COVID-19, those newly diagnosed with ovarian cancer, undergoing treatment, or in remission may have additional concerns – from weighing the need for treatment against exposure to the virus, to how the pandemic may be affecting routine care. We hope the following serves as a helpful resource.
NIH National Cancer Institute offers an array of information and resources for cancer patients; everything from understanding the novel coronavirus to questions about clinical trials. ASCO (American Society of Clinical Oncology) also speaks to how patient care may be modified in light of the pandemic, including information on therapies, surgery, screenings and more. If you have questions about whether treatment is necessary or can be delayed, please consult with your physician.
The Society of Gynecologic Oncology has released new guidelines for treatment in the time of COVID-19. These new recommendations provide helpful guidance for clinicians and gynecologic cancer patients alike, with emphasis on taking steps to avoid or minimize hospital visit when possible, and weighing risks of hospital visits against risk of infection. https://www.cancertherapyadvisor.com/home/cancer-topics/gynecologic-cancer/gynecologic-oncology-society-sgo-publishes-coronavirus-covid19-guidelines/
American Society of Clinical Oncology has provided updated guidance with important information and links to help you and your oncologist regarding the COVID vaccine booster shots.
Following CDC guidelines to protect against the novel coronavirus remains the standard protocol: washing hands properly, avoiding close contact with others, cleaning and disinfecting, and self-isolating as much as possible.
For those women who are in treatment or who remain at high risk, Evusheld, a monoclonal antibody, can be administered. It is FDA approved in certain populations and it is used to prevent Covid-19. Its protection lasts up to 6 months. It is not a substitute for vaccinations and it can’t be administered within 2 weeks of having received a Covid-19 vaccination. Please talk to your doctor to check your eligibility. You can read more about Evusheld here.
This video from OCRA’s oncology social worker, Tracy Moore, addresses some of the concerns that have been voiced within the ovarian and gynecologic cancer community, and offers some strategies for preserving our mental health while self-isolating:
If you’ve been impacted financially by the changes this crisis has brought about, you are far from alone. Fortunately, there is help available. View our list of financial support resources tailored specifically to help you through these challenging times.
Join our online Inspire community for information, support, encouragement, and camaraderie.
OCRA offers three different virtual support groups, taking place every Monday, Tuesday and Friday at 1pm EST. If you are interested in participating in a virtual support discussion facilitated by our Licensed Clinical Social Worker, please explore our offerings. This is a great way to meet others, share experiences and connect while social distancing. Registration is necessary so please sign up early to attend. Sponsorship support provided by GSK, AstraZeneca, Merck, and Gail Baird Foundation. Register here.
Connect with a trained peer mentor who knows what it’s like to navigate gynecologic cancer and wants to be there for someone newly diagnosed, facing recurrence, managing completion of therapy and off-treatment concerns, or fears of living with ovarian cancer in the COVID-19 times. Request a mentor match.
Woman to Woman is generously supported in part by grants from Gail Baird Foundation and Genentech.
We asked our Woman to Woman mentors to share messages of hope, along with their strategies for coping with these uncertain times. See what they have to say.
In April 2021, Dana-Farber Cancer Institute hosted a Spanish-language forum to talk about the COVID-19 vaccine. In this YouTube video of the forum, you can hear from three patients about their reasons for getting vaccinated, and view a Q&A with two Spanish-speaking clinicians.
Our partner Inspire surveyed tens of thousands of people about their vaccine experiences.
We invite you to contribute to a broader understanding of vaccine perceptions, symptoms, and access in the ovarian cancer community by taking the survey & exploring the results through Inspire’s interactive dashboard.